New Crypto Breakthrough Could Help You Make 947%, 1,453% and 1,945% in Only 12 Weeks

On April 23rd at 10 am ET, Luke Lango will reveal a new breakthrough that can help get you in front of cryptos before they surge 1,000% or more.

Tue, April 23 at 10:00AM ET
 
 
 
 
Details Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

A tickerboard of various stocks, all rated "Strong Buy"

Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now

Investors should not ignore these highly rated stocks to buy now because they deserve their reputation as the market heats up.

Two hand giving heap of coins money with up arrow and percentage symbol for financial banking increase interest rate or mortgage investment dividend from business growth concept. Dividend stocks

The Dividend Goldmine: 3 Shining Stocks With Growing Payouts

Explore opportunities in the cable, restaurant and biotechnology sectors, revealing how dividend growth stocks are maximizing returns.

Smiling piggy bank against stock chart background. Represents cheap stocks and stocks selling at a discount. stocks under $20. Cheap Growth Stocks

7 Stocks Under $15 Predicted to Boom in the Next 2 Years

Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash

By Rich Duprey, InvestorPlace Contributor
You never know when a downturn will hit so it pays to prepare for the worst by buying these stocks before a market crash.

CGC Stock Is on Watch Amid ‘Canopy USA’ Vote

By Josh Enomoto, InvestorPlace Contributor
With Canopy Growth pushing for a U.S.-centric entity, CGC stock has garnered intrigue as federal legalization sentiments rise.

Girl Power Portfolio: 3 High-Potential Stocks With Women CEOs to Buy Now

By Philippa Main, InvestorPlace Contributor
Stocks with women CEOs often outperform their counterparts. These three companies are great examples of that.

Underestimated Giants: 7 Stocks Set to Take Wall Street by Storm

By Yiannis Zourmpanos, InvestorPlace Contributor
Explore overlooked stocks to buy leading in entertainment, drug retail, integrated telecommunication, payment processing, and more.

AKAN Stock Pops as Akanda Eyes Entry into German Cannabis Market

By William White, InvestorPlace Writer
Akanda stock is rising higher on Friday after the cannabis company told AKAN investors it wants to expand its business into Germany.

Why Is Motus GI (MOTS) Stock Down 37% Today?

By William White, InvestorPlace Writer
Motus GI stock is falling hard on Friday following a delisting notice for MOTS shares that the company doesn't intend to appeal.

Why Is Allarity Therapeutics (ALLR) Stock Up 41% Today?

By William White, InvestorPlace Writer
Allarity Therapeutics stock is up on Monday alongside heavy trading of ALLR shares on a prospectus update from the company.

Why Is PaxMedica (PXMD) Stock Up 93% Today?

By William White, InvestorPlace Writer
PaxMedica stock is up on Friday with heavy trading of PXMD after announcing a new key milestone in PAX-101 drug development.

Wall Street Favorites: 3 Warren Buffett Stocks With Strong Buy Ratings for April 2024

By Chris Markoch, InvestorPlace Contributor
If you’re wondering where to invest in a stock picker's market, these three Warren Buffett stocks are a good place to start.

7 A-Rated Aggressive Biotech Stocks to Bet On in 2024

By Louis Navellier and the InvestorPlace Research Staff
We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades.

3 Must-Own Stocks for Sustained Growth Over the Next 18 Months

By Charles Munyi, InvestorPlace Contributor
Plan to buy these growth stocks since the market is significantly underpricing their potential for revenue upside over the next 18 months.

Trillion-Dollar Trajectories: 3 Billion-Dollar Stocks With the Potential to Hit the Next Milestone

By Rick Orford, InvestorPlace Contributor
Looking for your next picks? These top-performing market leaders have the potential to be the next trillion-dollar companies.

The 3 Most Promising MedTech Stocks to Invest In Now

By Jeremy Flint, InvestorPlace Contributor
MedTech stocks are often overlooked despite the inherent healthcare growth trajectory and industry-wide innovative spirit.

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

By Muslim Farooque, InvestorPlace Contributor
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments

3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024

By Ian Cooper, InvestorPlace Contributor
Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.

The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today

By Dana Blankenhorn, InvestorPlace Contributor
Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.

Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today?

By William White, InvestorPlace Writer
Aptevo Therapeutics stock is falling on Thursday after the company priced a public offering for 3.4 million shares of APVO.

Why Is Rallybio (RLYB) Stock Up 93% Today?

By William White, InvestorPlace Writer
Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.

3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition

By Larry Ramer, InvestorPlace Contributor
Wall Street often ignores the stocks of companies with huge potential. Here are three overlooked stocks to buy. 
Load More Articles